<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="rapid-communication" dtd-version="2.3">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">molbank</journal-id>
      <journal-title>Molbank</journal-title>
      <abbrev-journal-title abbrev-type="publisher">Molbank</abbrev-journal-title>
      <abbrev-journal-title abbrev-type="pubmed">Molbank</abbrev-journal-title>
      <issn pub-type="epub">1422-8599</issn>
      <publisher>
        <publisher-name>MDPI</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3390/M757</article-id>
      <article-id pub-id-type="publisher-id">molbank-2012-M757</article-id>
      <article-categories>
        <subj-group>
          <subject>Short Note</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title><italic>tert</italic>-Butyl 1-(Furan-2-yl)-4-oxo-2,3,7-triazaspiro[4.5]dec-1-ene-7-carboxylate</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Srinivasan</surname>
            <given-names>Rajagopalan</given-names>
          </name>
          <xref rid="af1-molbank-2012-M757" ref-type="aff">1</xref>
          <xref rid="af2-molbank-2012-M757" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Narayana</surname>
            <given-names>Badiadka</given-names>
          </name>
          <xref rid="af1-molbank-2012-M757" ref-type="aff">1</xref>
          <xref rid="c1-molbank-2012-M757" ref-type="corresp">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Samshuddin</surname>
            <given-names>Seranthimata</given-names>
          </name>
          <xref rid="af1-molbank-2012-M757" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sarojini</surname>
            <given-names>Balladka Kunhanna</given-names>
          </name>
          <xref rid="af3-molbank-2012-M757" ref-type="aff">3</xref>
        </contrib>
      </contrib-group>
      <aff id="af1-molbank-2012-M757"><label>1</label>Department of Studies in Chemistry, Mangalore University, Mangalagangotri-574 199, Karnataka, India</aff>
      <aff id="af2-molbank-2012-M757"><label>2</label>Aurigene Discovery Technologies Limited, Electronics city, Phase-II, Bangalore-560 100, Karnataka, India</aff>
      <aff id="af3-molbank-2012-M757"><label>3</label>Research Department of Chemistry, P. A College of Engineering, Nadupadavu, Mangalore 574153, Karnataka, India</aff>
      <author-notes>
        <corresp id="c1-molbank-2012-M757"><label>*</label> Author to whom correspondence should be addressed; E-Mail: <email>nbadiadka@yahoo.co.uk</email>.</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>24</day>
        <month>05</month>
        <year>2012</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>06</month>
        <year>2012</year>
      </pub-date>
      <volume>2012</volume>
      <issue>2</issue>
      <elocation-id>M757</elocation-id>
      <history>
        <date date-type="received">
          <day>27</day>
          <month>02</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>11</day>
          <month>05</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2012 by the authors; licensee MDPI, Basel, Switzerland.</copyright-statement>
        <copyright-year>2012</copyright-year>
        <license>
          <p>This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).</p>
        </license>
      </permissions>
      <abstract>
        <p>A simple and novel route for synthesis of new spirocyclic compound is developed. The present work involves condensation of ethyl nipecotate with 2-furaldehyde followed by the MnO<sub>2</sub> oxidation to give the <italic>&#x3B2;</italic>-keto ester which upon reaction with hydrazine hydrate gives the spiro pyrazolone.</p>
      </abstract>
      <kwd-group>
        <kwd>spirocyclic</kwd>
        <kwd>pyrazolone</kwd>
        <kwd>ethyl nipecotate</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introduction</title>
      <p>Spirocyclic compounds have attracted the attention of organic chemists due to their unique structural and reactivity pattern. These compounds represent an important class of naturally occurring substances characterized by their highly pronounced biological activities [<xref ref-type="bibr" rid="B1-molbank-2012-M757">1</xref>,<xref ref-type="bibr" rid="B2-molbank-2012-M757">2</xref>]. The spiro functionality shown in countless phytochemicals, such as in alkaloids, lactones, terpenoids, and clinically valuable compounds has been known for a long time. Arguably among the most challenging structural motifs to synthesize, all-carbon spirocyclics have inspired chemists for decades [<xref ref-type="bibr" rid="B3-molbank-2012-M757">3</xref>]. At present, spirocyclic compounds play a very important role in many fields such as chiral medicine, chiral LCD materials, macromolecule bulking agent and biological pesticides [<xref ref-type="bibr" rid="B4-molbank-2012-M757">4</xref>,<xref ref-type="bibr" rid="B5-molbank-2012-M757">5</xref>,<xref ref-type="bibr" rid="B6-molbank-2012-M757">6</xref>]. Because of the promising biological activity of spirocyclic compounds it was decided to prepare a new spiro-heterocyclic compound.</p>
    </sec>
    <sec sec-type="results">
      <title>Results and Discussion</title>
      <p>The title compound, <italic>tert</italic>-butyl 1-(furan-2-yl)-4-oxo-2,3,7-triazaspiro[4.5]dec-1-ene-7-carboxylate (<bold>3</bold>), was prepared by the condensation of 1-<italic>tert</italic>-butyl 3-ethyl 3-(furan-2-carbonyl)piperidine-1,3-dicarboxylate (<bold>2</bold>) with hydrazine hydrate in acidic medium (<xref ref-type="scheme" rid="molbank-2012-M757-sch001">Scheme 1</xref>). The intermediate <bold>2</bold> was in turn prepared by the condensation of ethyl nipecotate (<bold>1</bold>) with furfuraldehyde in presence of lithium diisopropyl amide (LDA) followed by MnO<sub>2</sub> oxidation [<xref ref-type="bibr" rid="B7-molbank-2012-M757">7</xref>,<xref ref-type="bibr" rid="B8-molbank-2012-M757">8</xref>,<xref ref-type="bibr" rid="B9-molbank-2012-M757">9</xref>]. The final product was well characterized by using NMR, IR and mass spectral data.</p>
      <p>The IR spectrum of compound (<bold>3</bold>) showed a wide absorption band at 3,412 cm<sup>&#x2212;1</sup> due to the presence of NH in the molecule. Two sharp bands at 1,693 and 1,624 cm<sup>&#x2212;1</sup> was due to Boc carbonyl and carbonyl group respectively. In <sup>1</sup>H-NMR spectrum, the signals of the respective protons of the title compound (<bold>3</bold>) were verified on the basis of their chemical shifts, multiplicities, and coupling constants. A broad singlet observed at &#x3B4; 11.4 ppm was due to the proton of pyrazolone NH. Nine protons of three methyl groups in Boc side chain resonated at &#x3B4; 1.3 ppm as a doublet. The eight protons of piperidine ring resonated in the region at &#x3B4; 1.4&#x2013;3.75 ppm as different signals due to chemical non-equivalence of these protons. The three protons of furan ring resonated at &#x3B4; 6.65, 7.06 and 7.84 ppm as a multiplet and two singlets respectively. The mass spectrum showed a peak at <italic>m/z</italic> 220 corresponding to M<sup>+</sup>-Boc group as the Boc group gets cleaved during the mass spectral conditions. Elemental analysis and <sup>13</sup>C-NMR spectrum also gave satisfactory results for the title compound.</p>
    </sec>
    <sec sec-type="methods">
      <title>Experimental </title>
      <p>Melting point was taken in open capillary tube and was uncorrected. The purity of the compound was confirmed by thin layer chromatography using Merck silica gel 60 F<sub>254</sub> coated aluminium plates. IR spectrum was recorded on Shimadzu-FTIR Infrared spectrometer in KBr (mmax in cm<sup>&#x2212;1</sup>). <sup>1</sup>H-NMR (400 MHz) spectrum was recorded on a Bruker AMX 400 spectrometer, with 5 mm PABBO BB -1H TUBES and <sup>13</sup>C-NMR (100 MHz) spectrum was recorded for approximately 0.03 M solutions in DMSO-d<sub>6</sub> at 100 MHz with TMS as internal standard. LCMS was obtained using Agilent 1200 series LC and Micromass zQ spectrometer. Elemental analysis was carried out by using VARIO EL-III (Elementar Analysensysteme GmBH).</p>
      <p>The condensation of ethyl nipecotate (<bold>1</bold>) with furfuraldehyde in THF in the presence of lithium diisopropyl amide (LDA) at &#x2212;78 &#xB0;C yielded 1-<italic>tert</italic>-butyl 3-ethyl 3-(furan-2-yl(hydroxy)methyl)piperidine-1,3-dicarboxylate [<xref ref-type="bibr" rid="B7-molbank-2012-M757">7</xref>,<xref ref-type="bibr" rid="B8-molbank-2012-M757">8</xref>] which on oxidation by MnO<sub>2</sub> yielded the intermediate, 1-<italic>tert</italic>-butyl 3-ethyl 3-(furan-2-carbonyl)piperidine-1,3-dicarboxylate (<bold>2</bold>) [<xref ref-type="bibr" rid="B9-molbank-2012-M757">9</xref>].</p>
      <p>To a solution of <bold>2</bold> (3.79 g, 10.78 mmole) in ethanol (20 mL), hydrazine hydrate, (99%, 5.0 mL, 100 mmole) was added followed by 0.3 mL of acetic acid. The reaction mixture was stirred at the ambient temperature for 6 h. After the completion of reaction as indicated by TLC, the reaction mixture was cooled to 0&#x2013;5 &#xB0;C and filtered. The product was washed with chilled ethanol (10 mL) followed by ether (10 mL) and dried to afford the title compound. Yield was 3.0 g, 87.2%.</p>
      <p>Melting point: 229&#x2013;232 &#xB0;C.</p>
      <p>LCMS: <italic>m/z</italic> = 220, (M<sup>+</sup>-Boc) + 1.</p>
      <p>IR (KBr): &#x3BD;<sub>max</sub> (cm<sup>&#x2212;1</sup>), 3412 (NH), 3097 (Furyl C-H), 2927 (aliphatic CH), 1693 (Boc C=O), 1624 (amide C=O), 1595 (C=N).</p>
      <p><sup>1</sup>H-NMR (400 MHz, DMSO-d<sub>6</sub>): &#x3B4; ppm, 1.3 (s, 9H, Boc-CH<sub>3</sub>), 1.4 (d, 2H, Piperidine-H, <italic>J</italic> = 12.4 Hz), 1.95 (m, 2H, Piperidine-H), 2.95 (m, 1H, Piperidine-H), 3.45 (d, 1H, Piperidine-H, <italic>J</italic> = 13.6 Hz), 3.75 (m, 2H, Piperidine-H), 6.65 (m, 1H, Furyl-H), 7.06 (s, 1H, Furyl-H), 7.84 (s, 1H, Furyl-H),11.4 (s, broad, 1H, pyrazolone &#x2013;NH).</p>
      <p><sup>13</sup>C-NMR (100 MHz, DMSO-d<sub>6</sub>): &#x3B4; ppm, 17.95 (CH<sub>2</sub> of piperidine), 27.96 (<italic>t</italic>-butyl-CH<sub>3</sub>), 43.29, 45.53, 46.74, 47.63 (Piperidine C&#x2019;s), 78.58 (Boc-CMe<sub>3</sub>), 111.18, 111.57, 145.81, 144.63 (Furyl), 150.65 (Pyrazolone-C), 153.35 (Boc-CO),177.05 (pyrazolone CO).</p>
      <p>Elemental analysis: Calculated for C<sub>16</sub>H<sub>21</sub>N<sub>3</sub>O<sub>4</sub>, C, 60.17%; H, 6.63%; N, 13.16%; Found: C, 60.13%; H, 6.64%; N, 13.13%.</p>
    </sec>
  </body>
  <back>
  <app-group>
    <app id="app1-molbank-2012-M757">
        <title>Supplementary materials</title>
        <supplementary-material id="molbank-2012-M757-s001" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2012-M757-s001-mod.mol">
   <label>Supplementary File 1</label>
</supplementary-material>
        <supplementary-material id="molbank-2012-M757-s002" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2012-M757-s001.mol">
   <label>Supplementary File 2</label>
</supplementary-material>
    </app>
</app-group>
    <ack>
      <title>Acknowledgments</title>
      <p>RS thanks Aurigene Discovery Technologies Limited and Mangalore University for research facilities. </p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="B1-molbank-2012-M757">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mead</surname>
              <given-names>K.T.</given-names>
            </name>
            <name>
              <surname>Brewer</surname>
              <given-names>B.N.</given-names>
            </name>
          </person-group>
          <article-title>Strategies in spiroketal synthesis revisited: Recent applications and advances</article-title>
          <source>Curr. Org. Chem.</source>
          <year>2003</year>
          <volume>7</volume>
          <fpage>227</fpage>
          <lpage>256</lpage>
          <pub-id pub-id-type="doi">10.2174/1385272033372969</pub-id>
        </citation>
      </ref>
      <ref id="B2-molbank-2012-M757">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shi</surname>
              <given-names>Z.-J.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>S.-L.</given-names>
            </name>
            <name>
              <surname>Cao</surname>
              <given-names>W.-G.</given-names>
            </name>
            <name>
              <surname>Deng</surname>
              <given-names>H.-M.</given-names>
            </name>
          </person-group>
          <article-title>Facile synthesis of a series of perfluoroalkyl-containing tetra-spirocyclic compounds and their spectral analysis</article-title>
          <source>Chin. J. Chem.</source>
          <year>2008</year>
          <volume>26</volume>
          <fpage>2103</fpage>
          <lpage>2106</lpage>
          <pub-id pub-id-type="doi">10.1002/cjoc.200890375</pub-id>
        </citation>
      </ref>
      <ref id="B3-molbank-2012-M757">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sannigrahi</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Stereocontrolled synthesis of spirocyclics</article-title>
          <source>Tetrahedron</source>
          <year>1999</year>
          <volume>55</volume>
          <fpage>9007</fpage>
          <lpage>9071</lpage>
          <pub-id pub-id-type="doi">10.1016/S0040-4020(99)00482-2</pub-id>
        </citation>
      </ref>
      <ref id="B4-molbank-2012-M757">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>Z.-H.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and application of chiral spiro ligands in asymmetric catalysis</article-title>
          <source>Chin. J. Org. Chem.</source>
          <year>2005</year>
          <volume>25</volume>
          <fpage>355</fpage>
          <lpage>363</lpage>
        </citation>
      </ref>
      <ref id="B5-molbank-2012-M757">
        <label>5.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Arai</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Kuraishi</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Arai</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Sasai</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>A new asymmetric Wacker-type cyclization and tandem cyclization promoted by Pd(II)-spiro bis(isoxazoline) catalyst</article-title>
          <source>J. Am. Chem. Soc.</source>
          <year>2001</year>
          <volume>123</volume>
          <fpage>2907</fpage>
          <lpage>2908</lpage>
          <pub-id pub-id-type="doi">10.1021/ja005920w</pub-id>
          <pub-id pub-id-type="pmid">11456988</pub-id>
        </citation>
      </ref>
      <ref id="B6-molbank-2012-M757">
        <label>6.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pan</surname>
              <given-names>C.-Y.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>William</surname>
              <given-names>J.B.</given-names>
            </name>
          </person-group>
          <article-title>The investigation of polymerization mechanism of 7-methylene-2-methyl-1,4,6-triox-aspiro(4,4)nonane</article-title>
          <source>Acta Polym. Sin.</source>
          <year>1989</year>
          <volume>1</volume>
          <fpage>18</fpage>
          <lpage>24</lpage>
        </citation>
      </ref>
      <ref id="B7-molbank-2012-M757">
        <label>7.</label>
        <citation citation-type="patent">
          <person-group person-group-type="author">
            <name>
              <surname>Aslanian</surname>
              <given-names>R.G</given-names>
            </name>
            <name>
              <surname>Bennett</surname>
              <given-names>C.E.</given-names>
            </name>
            <name>
              <surname>Burnett</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>T.-Y.</given-names>
            </name>
            <name>
              <surname>Kiselgof</surname>
              <given-names>E.Y.</given-names>
            </name>
            <name>
              <surname>Knutson</surname>
              <given-names>C.E.</given-names>
            </name>
            <name>
              <surname>Harris</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Mc Kittrick</surname>
              <given-names>B.A.</given-names>
            </name>
            <name>
              <surname>Palani</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>E.M.</given-names>
            </name>
            <name>
              <surname>Vaccaro</surname>
              <given-names>H.M.</given-names>
            </name>
            <name>
              <surname>Xiao</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>H.M.</given-names>
            </name>
          </person-group>
          <article-title>Azetidinone derivatives and methods of use thereof</article-title>
          <patent>WO2008033464(A2)</patent>
		  <day>20</day>
		  <month>March</month>
          <year>2008</year>
        </citation>
      </ref>
      <ref id="B8-molbank-2012-M757">
        <label>8.</label>
        <citation citation-type="patent">
          <person-group person-group-type="author">
            <name>
              <surname>Theodoridis</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Rosen</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Yeager</surname>
              <given-names>W.H.</given-names>
            </name>
            <name>
              <surname>Henrie</surname>
              <given-names>I.R.N.</given-names>
            </name>
            <name>
              <surname>Ahmed</surname>
              <given-names>S.Z.</given-names>
            </name>
            <name>
              <surname>Men</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Donovan</surname>
              <given-names>S.F.</given-names>
            </name>
          </person-group>
          <article-title><italic>N</italic>-Substituted azacycles</article-title>
          <patent>WO2005036961(A2)</patent>
		  <day>28</day>
		  <month>April</month>
          <year>2005</year>
        </citation>
      </ref>
      <ref id="B9-molbank-2012-M757">
        <label>9.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Corey</surname>
              <given-names>E.J.</given-names>
            </name>
            <name>
              <surname>Gilman</surname>
              <given-names>N.W.</given-names>
            </name>
            <name>
              <surname>Ganem</surname>
              <given-names>B.E.</given-names>
            </name>
          </person-group>
          <article-title>New methods for the oxidation of aldehydes to carboxylic acids and esters</article-title>
          <source>J. Am. Chem. Soc.</source>
          <year>1968</year>
          <volume>90</volume>
          <fpage>5616</fpage>
          <lpage>5617</lpage>
          <pub-id pub-id-type="doi">10.1021/ja01022a059</pub-id>
        </citation>
      </ref>
    </ref-list>
    <sec sec-type="display-objects">
      <title>Scheme</title>
      <fig id="molbank-2012-M757-sch001" position="float">
        <object-id pub-id-type="pii">molbank-2012-M757-sch001_Scheme 1</object-id>
        <label>Scheme 1</label>
        <caption>
          <p>Synthesis of <italic>tert</italic>-butyl 1-(furan-2-yl)-4-oxo-2,3,7-triazaspiro[4.5]dec-1-ene-7-carboxylate.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2012-M757-sch001.tif"/>
      </fig>
    </sec>
  </back>
</article>
